| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.52B | 65.40B | 59.98B | 55.70B | 52.66B | 49.68B |
| Gross Profit | 20.10B | 19.72B | 16.77B | 16.30B | 18.10B | 17.25B |
| EBITDA | 14.49B | 14.24B | 12.85B | 11.20B | 12.99B | 12.17B |
| Net Income | 8.74B | 8.21B | 7.35B | 6.38B | 7.71B | 7.28B |
Balance Sheet | ||||||
| Total Assets | 144.50B | 145.73B | 136.60B | 126.26B | 119.96B | 111.68B |
| Cash, Cash Equivalents and Short-Term Investments | 56.24B | 58.96B | 50.21B | 56.80B | 64.90B | 60.38B |
| Total Debt | 15.86M | 18.03M | 26.27M | 34.43M | 42.87M | 4.13M |
| Total Liabilities | 17.51B | 17.35B | 16.32B | 14.52B | 13.63B | 12.81B |
| Stockholders Equity | 125.77B | 127.10B | 119.18B | 110.76B | 105.49B | 98.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.21B | 5.76B | 2.57B | 5.93B | 9.50B |
| Operating Cash Flow | 0.00 | 12.17B | 8.81B | 5.60B | 8.30B | 11.02B |
| Investing Cash Flow | 0.00 | 675.47M | -14.50B | -1.92B | 7.06B | 4.28B |
| Financing Cash Flow | 0.00 | -3.54B | -3.28B | -3.09B | -2.48B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥131.25B | 6.86 | ― | 1.08% | 0.48% | -4.27% | |
72 Outperform | ¥1.49T | 18.60 | 11.19% | 1.46% | 2.65% | -5.76% | |
71 Outperform | ¥566.58B | 19.60 | 9.28% | 1.30% | 5.50% | 27.32% | |
68 Neutral | ¥302.69B | 10.81 | 4.15% | 1.66% | 0.74% | 5.88% | |
67 Neutral | ¥184.41B | 15.27 | 7.21% | 3.24% | 2.42% | 66.96% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥4.58T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% |